Specialty Chemicals

NHU released FY2026 Q1 earnings on April 28 During-Market (BJT), actual revenue CNY 6.295 B (forecast CNY 5.693 B), actual EPS CNY 0.59 (forecast CNY 0.6397)

NHU to release FY2026 Q1 earnings on April 29 During-Market BJT, forecast revenue CNY 5.693 B, EPS CNY 0.6397

NHU released FY2025 Q4 earnings on April 15 After-Market (BJT), actual revenue CNY 5.609 B (forecast CNY 5.903 B), actual EPS CNY 0.4785 (forecast CNY 0.4179)

NHU released FY2025 Annual Earnings on April 15 After-Market (BJT), but actual revenue and EPS are reported as CNY 0

NHU to Release FY2025 Annual Earnings on April 16 After-Market (BJT), Forecast Revenue CNY 23.24 B, EPS CNY 2.1759

NHU released FY2025 9 Months Earnings on October 28 During-Market (BJT), actual revenue CNY 16.64 B, actual EPS CNY 1.7298

NHU released FY2025 Q3 earnings on October 28 During-Market (BJT), actual revenue CNY 5.541 B (forecast CNY 6.093 B), actual EPS CNY 0.5599 (forecast CNY 0.4963)

NHU to release FY2025 Q3 earnings on October 29 during market hours (BJT), forecast revenue CNY 6.093 B, EPS CNY 0.4963

NHU released FY2025 semi-annual earnings on August 27 During-Market (BJT), actual revenue CNY 11.1 B, actual EPS CNY 1.17

NHU released FY2025 Q2 earnings on August 27 During-Market (BJT), actual revenue CNY 5.661 B (forecast CNY 5.776 B), actual EPS CNY 0.5599 (forecast CNY 0.4963)

NHU to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Newchinal plans to carry out scheduled maintenance on methionine production line

Eastwu Securities Gives Xinhecheng a 'Buy' Rating

NewChang Shows Significant Advantages in Vitamin Business

New and Cheng Responds to Progress of Liquid Methionine and New Materials Projects

Newhechen Responds to Investor Queries on Liquid Methionine Project Mass Production

Xinhua Cheng Expected to See Significant Profit Growth in H1 2025

Newheekong and Sinopec JV Liquid Methionine Project Enters Trial Production

Xinhua Cheng Plans to Expand PPS Capacity

Senior Executives of Xinhecheng Increase Holdings by 200,000 Shares

Ordinary dividend (cash)

Ex Date: 2026.05.28, Cash dividend 0.8 CNY

002001

According to the Zhitong Finance APP, NHU announced that as of October 31, 2025, the company repurchased 20,082,692 shares through centralized bidding, accounting for 0.6534% of the company's total share capital, with a total transaction amount of 446 million yuan (excluding transaction fees)

Zhitong

NHU has repurchased a total of 20.0827 million shares at a cost of 446 million yuan

NHU announced that its revenue for the third quarter was 5.541 billion yuan, a decrease of 6.66%; net profit was 1.717 billion yuan, a decrease of 3.80%. Revenue for the first three quarters was 16.642 billion yuan, a year-on-year increase of 5.45%; net profit was 5.321 billion yuan, a year-on-year increase of 33.37%

NHU: Net profit in the third quarter was 1.717 billion yuan, a decrease of 3.80%

Zhejiang NHU Co., Ltd. announced the implementation of the 2025 semi-annual equity distribution, distributing cash of 2 yuan per 10 shares based on 3,058,605,988 shares, with a total amount of 611,721,197.60 yuan. The equity registration date is October 17, 2025, and the ex-dividend date is October 20. At the same time, the upper limit for the repurchase price of shares has been adjusted from 31.50 yuan per share to 31.30 yuan per share, with the expected repurchase range being 9,584,664 shares to 19,169,329 shares, accounting for 0.31% to 0.62% of the total share capital

NHU will implement the 2025 semi-annual equity distribution, adjusting the repurchase price ceiling

On September 4th, NHU stated at a strategy meeting that the company adheres to the main strategy of "Chemicals +" and "Biotechnology +", seizing development opportunities in industries such as nutrition and health, new materials, flavors and fragrances, and active pharmaceutical ingredients. In recent years, it has launched new products such as serine, tryptophan, and cysteine. The Tianjin nylon new materials project is currently being promoted, and there are plans to reserve a thousand acres of land for the construction of a fragrance project. In the future, it will promote the HA project and the PPS expansion construction project in conjunction with market conditions, with a rich reserve of projects

NHU: Reserves of thousands of acres of land planned for the construction of a spice project

On August 30th, NHU stated on the investor interaction platform that the company currently has no cholesterol production line

NHU: The company currently has no cholesterol production line

NHU announced that in the first half of 2025, operating revenue reached 11.101 billion yuan, a year-on-year increase of 12.76%. Net profit was 3.603 billion yuan, a year-on-year increase of 63.46%

NHU: Net profit of 3.603 billion yuan in the first half of 2025, a year-on-year increase of 63.46%

NHU stated on the interactive platform on August 23 that the company's current annual production capacity for taurine is 30,000 tons, and sales volume and sales amount are not disclosed separately. The sales volume and sales amount of taurine products have both been in an upward phase year-on-year this year

NHU: The sales volume and sales revenue of taurine products have both been in an upward phase this year compared to the same period last year

According to the Zhitong Finance APP, NHU released its performance forecast for the first half of 2025, expecting a net profit attributable to shareholders of the listed company to be between 3.3 billion yuan and 3.75 billion yuan, a year-on-year increase of 50% to 70%. During the reporting period, the sales volume and sales price of the main products in the nutrition segment increased compared to the same period last year, resulting in improved operating performance

NHU expects an increase, with net profit attributable to the parent company in the first half of the year between 3.3 billion yuan and 3.75 billion yuan, a year-on-year growth of 50% to 70%

On June 23rd, NHU stated on the interactive platform that the liquid methionine project in joint venture cooperation with Sinopec has entered the trial production stage, progressing smoothly, and has successfully produced qualified products

SINOPEC CORP

NHU: The liquid methionine project in joint venture cooperation with Sinopec has entered the trial production stage

NHU stated today on the interactive platform that the company's current annual production capacity for PPS is 22,000 tons, and it aims to achieve a 100% capacity utilization rate in 2024. The company will plan for expansion based on market demand

NHU(002001.SZ)